Huaxia Eye (China) Today
Huaxia Eye is trading at 17.57 as of the 5th of February 2025, a 1.4% down since the beginning of the trading day. The stock's open price was 17.82. The performance scores are derived for the period starting the 6th of January 2025 and ending today, the 5th of February 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | Category Healthcare | Classification Health Care |
Valuation Profit Patterns
Check how we calculate scores
Huaxia Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Huaxia Eye's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Huaxia Eye or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman Manager | Qingcan Su |
| Thematic Idea | Health Management (View all Themes) |
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, Health Management, Health Care, Health Care Providers & Services, Medical Care Facilities, Healthcare (View all Sectors) |
Huaxia Eye Hospital (301267) is traded on Shenzhen Stock Exchange in China and employs 7,613 people. Huaxia Eye is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 19.98 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Huaxia Eye's market, we take the total number of its shares issued and multiply it by Huaxia Eye's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Huaxia Eye Hospital operates under Health Care Providers & Services sector and is part of Health Care industry. The entity has 840 M outstanding shares.
Huaxia Eye generates positive cash flow from operations, but has no cash available
Check Huaxia Eye Probability Of Bankruptcy
Huaxia Eye Hospital Risk Profiles
Although Huaxia Eye's alpha and beta are two of the key measurements used to evaluate Huaxia Eye's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.65 | |||
| Standard Deviation | 2.15 | |||
| Variance | 4.61 | |||
| Risk Adjusted Performance | (0.12) |
Huaxia Stock Against Markets
Huaxia Eye Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Huaxia Eye stock to make a market-neutral strategy. Peer analysis of Huaxia Eye could also be used in its relative valuation, which is a method of valuing Huaxia Eye by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Other Information on Investing in Huaxia Stock
Huaxia Eye financial ratios help investors to determine whether Huaxia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Huaxia with respect to the benefits of owning Huaxia Eye security.